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Chapter Abstract
Evidence-based knowledge of infectious disease burden, including prevalence, inci-
dence, severity and transmission, in different population strata and locations, and
possibly in real time, is crucial to the planning and evaluation of public health
policies. Direct observation of a disease process is rarely possible. However, latent
characteristics of an epidemic and its evolution can often be inferred from the syn-
thesis of indirect information from various routine data sources, as well as expert
opinion. The simultaneous synthesis of multiple data sources, often conveniently
carried out in a Bayesian framework, poses a number of statistical and compu-
tational challenges: the heterogeneity in type, relevance and granularity of the
data, together with selection and informative observation biases, lead to complex
probabilistic models that are difficult to build and fit, and challenging to criti-
cize. Using motivating case studies of influenza, this chapter illustrates the cycle
of model development and criticism in the context of Bayesian evidence synthesis,
highlighting the challenges of complex model building, computationally efficient
inference, and conflicting evidence.
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Chapter 1
Analysing Multiple Epidemic
Data Sources
1.1 Introduction
“A catalogue of the number of deaths induced by the major epi-
demics of historical time is staggering, and dwarfs the total deaths
on all battlefields.” (Anderson and May, 1991)
This quote sets the problem of infectious diseases in perspective. Although
major historical threats have been defeated (Heesterbeek et al., 2015), new
emerging ones continue to challenge humans. It is not surprising that in-
creasing effort has been made by policy makers to assess and anticipate the
consequence of epidemics. Evidence-based knowledge of disease burden, in-
cluding prevalence, incidence, severity, and transmission, in different popu-
lation strata, in different locations and, if feasible, in real time, is becoming
progressively key to the planning and evaluation of public health policies
(Heesterbeek et al., 2015). Direct observation of a disease process is hardly
ever possible. However, retrospective and prospective estimation of the key
aspects of burden listed above is feasible through the use of indirect infor-
mation collected in administrative registries. The previous chapters in this
handbook (and the rich literature that exists, e.g. (Heesterbeek et al., 2015;
Birrell et al., 2018) and references therein) provide plenty of examples of how
surveillance information, together with statistical models, can be used to re-
construct the disease process underlying the pattern of the observed data,
infer the unobserved (latent) characteristics of the epidemic and forecast its
evolution.
Here we focus, in particular, on statistical inference that makes simulta-
neous use of multiple data sources, including different streams of surveillance
1
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data, ad hoc studies and expert opinion.
This ‘evidence synthesis’ approach is not new in medical statistics. Meta-
analysis and network meta-analysis are well established approaches to com-
bine data from studies of similar design, typically clinical trials (Borenstein
et al., 2009). The idea has been generalised in the areas of medical decision-
making (Eddy et al., 1992), technology assessment (Spiegelhalter et al., 2004;
Welton et al., 2012) and epidemiology (e.g. (Ades and Sutton, 2006)) to
assimilate data from sources of different types and/or studies of different
designs and is becoming popular in other scientific fields, as modern tech-
nologies enable the collection and storage of ever increasing amounts of in-
formation (e.g. (Wheldon et al., 2015; Clark et al., 2017)). For infectious
disease, in the last ten years there has been a proliferation of papers employ-
ing multiple sources of information to reconstruct characteristics of epidemics
of blood borne and respiratory diseases, including estimation of prevalence
(e.g. HIV (De Angelis et al., 2014), HCV (Harris et al., 2012; McDonald
et al., 2014a), campylobacteriosis (Albert et al., 2011)), severity (e.g. (Pre-
sanis et al., 2014; Shubin et al., 2014)), incidence (e.g. toxoplasmosis (Welton
and Ades, 2005), influenza (McDonald et al., 2014b) and pertussis (Mcdonald
et al., 2015)) and transmission (e.g. influenza (Birrell et al., 2011; Dorigatti
et al., 2013)).
The use of multiple data sources poses a number of statistical and compu-
tational challenges: the combination of various sources, most likely affected
by selection and informative observation biases and heterogeneous in type,
relevance and granularity, leads to probabilistic models with complex struc-
tures, difficult to build and fit and challenging to criticize (De Angelis et al.,
2014).
In this chapter, we will use motivating case studies of influenza to in-
troduce the evidence synthesis setting in infectious diseases, illustrate the
building and fitting of relevant models, and highlight the opportunities of-
fered and the challenges posed by the multiplicity of sources. The models we
will concentrate on are typically Bayesian, as this framework offers a natural
setup for the synthesis of information.
The chapter is organised as follows: in Section 1.2, we describe our moti-
vating examples; in Section 1.3, the generic framework for evidence synthesis
for infectious diseases is introduced; the models developed for the chosen
examples are presented in Sections 1.4 and 1.5; Section 1.6 is devoted to the
challenges encountered in the building, fitting and criticism of models that
incorporate multiple sources; we conclude with a final discussion in Section
1.7.
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Figure 1.1: Severity of influenza as a “pyramid”: infected individuals progress
from asymptomatic infection (‘I’) to symptomatic infection (‘S’), hospitalisa-
tion (‘H’), ICU-admission (‘ICU’) and/or death (‘D’). Case-severity risks, i.e.
the case-hospitalisation (CHR), case-ICU-admission (CIR) and case-fatality
(CFR) risks, are defined as probabilities of a severe event given infection.
1.2 Motivating example: influenza
Public health responses aimed at mitigating the impact of an outbreak need
reliable (and prompt) assessment of the likely severity and spread of the infec-
tion. This understanding is particularly key when a new pathogen emerges,
potentially causing a pandemic, for example a new influenza strain as in 2009
(Lipsitch et al., 2009) or more recently, the zika (Kucharski et al., 2016) and
ebola (Camacho et al., 2015) outbreaks.
We will use examples of influenza severity and transmission estimation, in
particular referring to the 2009 A/H1N1 pandemic in the United Kingdom,
to illustrate how, in the absence of ideal information, estimation of severity
and transmission can be carried out by using data from a multiplicity of
sources.
1.2.1 Severity
The severity of an infectious disease, such as influenza, can be thought as a
“pyramid” (Figure 1.1), where with increasing severity, there are fewer and
fewer infections. A proportion of infected individuals progress to symptoms,
then to hospitalisation, and the most severe end-points of either intensive
care (ICU) admission or death. Severity is usually expressed as “case-severity
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risks” (CSRs), i.e. probabilities that an infection leads to a severe event such
as being hospitalised, admitted to ICU, or dying. Quantification of such risks
is necessary both prospectively, in the midst of an outbreak, to understand
the severity and likely burden on health-care of an ongoing epidemic; and
retrospectively, to assess the severe burden of the particular strain responsible
for the epidemic and the adequacy of any public health response during the
outbreak, and to inform responses in future outbreaks. However, such CSRs
are challenging to directly observe, requiring therefore estimation.
Prospectively, estimation would require a cohort of cases, i.e. individuals
with laboratory-confirmed influenza, to be followed up over time. However,
a representative sample of those who are infected is almost impossible to
recruit, particularly as infections that are asymptomatic are less likely to
be observed in health-care data than symptomatic infections. Even if it
were possible, prospective estimation would have to account appropriately
for censoring, as the end points of interest might take time to occur.
For retrospective estimation, censoring may not be an issue, however, dif-
ferential probabilities of observing cases at different levels of severity (ascer-
tainment/detection probabilities) may lead to biases (Lipsitch et al., 2009).
‘Multiplier’ methods (Reed et al., 2009; Shrestha et al., 2011; Reed et al.,
2015) therefore have been proposed when individual-level survival-type data
are not available, combining aggregate case numbers at different levels of
severity (e.g. surveillance data on sero-prevalence i.e. the proportion of blood
samples testing positive for influenza; general practice (GP) consultations for
influenza-like-illness (ILI); hospital/ICU admissions; mortality) to obtain es-
timates of the CSRs. These methods account for the ascertainment/detection
biases suffered by aggregate surveillance data, through multiplication by in-
verse proportions detected, with informal uncertainty quantification using
Monte Carlo forward simulation (e.g. (Reed et al., 2009; Shrestha et al.,
2011)).
Hybrid methods, that combine hierarchical models with multiplier meth-
ods in different stages, have appeared recently (Reed et al., 2015). However,
multiplier methods to estimate severity were first formalised using Bayesian
evidence synthesis, to simultaneously account for uncertainty, prior informa-
tion on some ascertainment/detection biases, and censoring (Presanis et al.,
2009; Presanis et al., 2011; Presanis et al., 2014). The uncertainty inherent
in each data source, together with prior uncertainty, is propagated formally
through to posterior estimates of the CSRs. The estimated CSRs are derived
as products of probabilities of being at one severity level conditional on being
at lower severity level (Figure 1.1).
Such an evidence synthesis is presented in (Presanis et al., 2014), for the
A/H1N1 pandemic in England during each of three waves experienced in sum-
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mer 2009, the 2009/2010 and 2010/2011 seasons. The available data sources
include: (i) cross-sectional sero-prevalence data from laboratory-tested resid-
ual sera from patients after diagnostic testing for various (non-respiratory)
conditions. These data, over time, inform changes in the proportion of the
population exposed to influenza strains, i.e. the population level of im-
munity, and hence indirectly inform incidence; (ii) estimates of numbers
symptomatic based on potentially under-ascertained GP consultations for
“influenza-like-illness” (ILI) and corresponding data on the proportion of
nasopharyngeal swabs from individuals with ILI that test virologically pos-
itive for the A/H1N1pdm strain; (iii) under-ascertained retrospective and
prospective daily hospital admissions from 129 hospital trusts in the first
two waves, and a sentinel set of 23 trusts in the third wave (Figure 1.2(A));
(iv) under-ascertained numbers of deaths occurring in individuals with con-
firmed A/H1N1 infection (Figure 1.2(B)). Each source poses a number of
challenges, in addition to the above-mentioned ascertainment/detection bi-
ases. The sero-prevalence data, although available for all three waves, in the
second and third waves, does not allow separation of individuals with anti-
bodies in response to vaccination from infected individuals. Point estimates
of the number symptomatic from the Health Protection Agency (HPA) are
only available in the first two waves, with an informal “uncertainty range”
from sensitivity analyses. For the third wave, such estimates are instead ob-
tained from a joint regression model of the GP ILI and virological positivity
data, based on a much smaller sentinel set of general practices than the more
comprehensive sentinel system used in the first two waves. Both the GP
and positivity datasets are required, to disentangle ILI consultations due to
“background” consultations for other respiratory illness from actual influenza
consultations. The switch from a comprehensive to a sentinel hospital sys-
tem between the second and third waves results in sparser data and changes
in the age groups recorded (Figure 1.3), particularly affecting the number of
severe outcomes (ICU admissions and deaths) reported in the hospitalisation
data: no deaths are observed in the third wave. This sparsity requires the
use of an additional ICU data source, which poses its own challenge. The
system measures prevalent cases present in ICU, rather than incident or cu-
mulative incident ICU admissions, and hence requires a model of the process
of admissions and discharges to obtain estimates of cumulative admissions.
None of the data sources on their own can provide an estimate of all CSRs
of interest. However, by combining them all in a Bayesian evidence synthesis,
the challenges described above can be resolved to derive the necessary severity
estimates, as presented in Section 1.4.
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(A) A/H1N1 hospitalisations by admission week
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(B) A/H1N1 deaths by date of death
Figure 1.2: Frequency of observed severe events relative to the total number
of events over the period April 2009-March 2011 of the three waves of in-
fection, among individuals with confirmed A/H1N1 pandemic influenza: (A)
weekly hospitalisations; (B) daily deaths.
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(B) deaths per hospitalisation
Figure 1.3: Proportion of observed individuals hospitalised with confirmed
A/H1N1 pandemic influenza who experienced severe events during the three
waves of infection: (A) ICU admissions per confirmed A/H1N1 hospitalisa-
tion, by age and wave; (B) deaths per confirmed A/H1N1 hospitalisation, by
age and wave.
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1.2.2 Transmission
Understanding the dynamics of an infectious disease amounts to estimation
of the rate at which it spreads and the factors that are contributing to its
spread. To acquire such knowledge, mechanistic transmission models are used
(Anderson and May, 1991), expressed by differential equations describing the
disease dynamics resulting from the interaction between individuals at differ-
ent disease stages. For instance, in the susceptible-infectious-recovered (SIR)
model new infections are generated through the contact between susceptible
and infectious individuals, i.e. in state S and I, respectively. For influenza,
and other respiratory infections, the relevant contact is between different age
groups, since school-age children and their interactions with both other chil-
dren and adults are known to be key drivers of transmission (Cauchemez
et al., 2008). Historically, studies of influenza transmission have been carried
out either by simulation (Heesterbeek et al., 2015) or by estimating the pa-
rameters of transmission models using direct information from a single time
series of disease endpoints, such as confirmed cases (e.g. (Cauchemez et al.,
2008)).
However, in recent years the need and potential of combining data from
multiple sources to infer latent characteristics of epidemics has been increas-
ingly recognised. For influenza, in particular, since the 2009 A/H1N1 in-
fluenza pandemic, this recognition resulted in the development of a number
of transmission models using data from either multiple surveillance time se-
ries (e.g. (Birrell et al., 2011; Dorigatti et al., 2013; Baguelin et al., 2013; Te
Beest et al., 2014; Shubin et al., ; Birrell et al., 2016)) or a combination of
surveillance and phylogenetic data (e.g. (Ypma et al., 2012; Ratmann et al.,
2012; Jombart et al., 2014)). The integration of different sources of evidence
can ensure identification of interpretable parameters in transmission models
and a more comprehensive description of the evolution of an outbreak (De
Angelis et al., 2014).
An example is given in (Birrell et al., 2011) where, in the absence of a
complete time series of confirmed influenza cases, various data sources are
used to estimate retrospectively transmission during the first two waves of
pandemic A/H1N1 influenza infection. Figure 1.4 shows the data for the
London region: (A) GP consultations for ILI from May to December 2009;
(B) a series of cross-sectional samples from sero-prevalence surveys (see Sec-
tion 1.2.1); (C) virological data on nasopharyngeal positivity for A/H1N1
(again as in Section 1.2.1); and (D) a limited time series of confirmed cases
in the first few weeks of the outbreak, up till June 2009, when contact trac-
ing ceased. As in Section 1.2.1, GP consultation data are contaminated by
individuals experiencing non-A/H1N1-related ILI, whose health-care seeking
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behaviour is highly influenced by governmental advice and media report-
ing. To reconstruct the underlying pattern of A/H1N1 infections, GP data
had to be combined with information on A/H1N1 virological positivity, on
population immunity from the serological surveys, knowledge on the natural
history of A/H1N1, including the probability of developing symptoms, and
data on the propensity of patients with symptomatic infections to consult a
GP (Brooks-Pollock et al., 2011).
1.3 Bayesian evidence synthesis
The notion of evidence synthesis is intrinsic to the Bayesian philosophy of
assimilating information, Bayes’ theorem being the basis for the combination
of prior and new evidence. Generalising the concepts of meta-analysis and
network meta-analysis, the evidence synthesis described and used here com-
bines information from different study designs, through complex hierarchical
models (Ades and Sutton, 2006; De Angelis et al., 2014; De Angelis et al.,
2014).
A useful graphical representation Bayesian hierarchical models have a
long history of being expressed as directed acyclic graphs (DAGs), encoding
the dependency structure between variables in the model (Lauritzen, 1996).
A generic evidence synthesis model can be represented graphically as in
Figure 1.5. Square nodes represent observable quantities such as yi, whereas
circles are latent quantities, such as ψi. Double circles such as θj are founder
nodes, i.e. parameters to which a prior distribution is assigned. Dashed
rectangles, or “plates”, represent repetition over indices, such as i ∈ 1, . . . , n.
Dependencies between variables are indicated by direct arrows, with solid and
dashed arrows representing distributional (stochastic) and functional (deter-
ministic) dependencies, respectively. The joint distribution of all quantities
in the DAG is the product of the conditional distributions of each node given
its direct parents. The aim of an evidence synthesis model such as Figure
1.5 is to estimate a set of k basic parameters θ = {θ1, . . . , θk}, based on a
set of n independent datasets y = {y1, . . . ,yn}, where n is not necessarily
equal to k. Each dataset yi, i ∈ 1, . . . , n is assumed to inform a quantity (a
functional parameter) ψi = ψi(θ) that can be expressed as a deterministic
function of the basic parameters. If ψi ≡ θj for some j ∈ 1, . . . , k, yi is
said to directly inform θj. Otherwise, for ψi = ψi(θ), yi indirectly informs
multiple parameters in the basic parameter set, in conjunction with all the
other datasets. Further functional quantities ψi = ψi(θ), i > n may be of
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(D) Weekly confirmed cases
Figure 1.4: Four data streams used in the transmission model of (Birrell
et al., 2011): (A) GP ILI consultations; (B) serological positivity; (C) vi-
rological positivity; (D) confirmed cases. Each plot shows the frequency of
events (consultations per 100,000 population, positive & negative sera sam-
ples, positive & negative swabs, confirmed cases respectively) relative to the
total number of respective events over the period April 2009-December 2009
of the first two waves of infection.
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θj
i = 1, . . . , n
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ψi
i = n + 1, . . . , N
Functions
Figure 1.5: Directed acyclic graph of a generic evidence synthesis model.
interest to derive from the basic parameters, even if no data directly inform
such functions. Assuming the independence of each dataset yi, i ∈ 1, . . . , n
conditional on their common parents, the posterior distribution of the basic
parameters θ given the data y is
p(θ | y) ∝ p(θ)
n∏
i=1
p(yi | ψi(θ)) = p(θ)
n∏
i=1
p(yi | θ).
Such an evidence synthesis model and DAG can clearly be extended both
horizontally (more datasets) and vertically (hierarchical modelling).
Many evidence synthesis models used in the epidemic literature can be
usefully represented graphically by DAGs (Andersen and Keiding, 2002; Bir-
rell et al., 2016; Jackson et al., 2015). Figure 1.6 is a generic DAG repre-
sentation of a population-level multi-state disease transmission model where
the vector-valued X(t) = (X1(t), . . . , XK(t)) corresponds to either the num-
ber or proportion of the population in each disease state 1, . . . , K at time
t. Movement between states is governed by transition rates λ(t), which are
parameterised in terms of a collection of unknown basic parameters θ(t),
and the current state of the system X(t). If transmission is not explicitly
modelled, the dependence of λ(t) on the states X(t), represented by the
dashed arrow from X(t) to λ(t), is removed, and the model simplifies to
a standard linear multi-state model. Typically, the X(t) and λ(t) are not
directly observed. Instead, as in the simpler case of Figure 1.5, observations
yt,i, i = 1, . . . , nt are available at time t, with each yt,i informing a functional
parameter ψt,i = ψt,i(X(t),λ(t). These relationships may be stochastic de-
pendencies, or more usually, deterministic functions. Again assuming that
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Figure 1.6: Directed acyclic graph of a multi-state model representing a
transmission model embedded in an evidence synthesis.
the yt,i for i = 1, . . . , nt are independent conditional on their common par-
ents, the likelihood of the data yt = (yt,i, i = 1, . . . , nt) at time t is expressed
as the product
L(yt |X(t),λ(t)) =
nt∏
i=1
L(yt,i | ψt,i(X(t),λ(t))).
When the data are also conditionally independent over time, the likeli-
hood of all the data y = (y0,1, . . . ,yt,nt) given the basic parameters θ =
(θ0, . . . ,θt, . . .) is
L(y | θ) =
∏
t
nt∏
i=1
L(yt,i | ψt,i(X(t),λ(t))) =
∏
t
nt∏
i=1
L(yt,i | θt).
The posterior distribution of θ given the data is then p(θ | y) ∝ L(y | θ)p(θ).
Note that given the posterior distribution of the basic parameters and/or
the states and transition rates, any function ψ(θ,λ,X), even if not directly
observed, can be derived.
1.4 Cross-sectional estimation: severity
Static, cross-sectional models to estimate prevalence or cumulative incidence
of (perhaps severe) disease are particular cases of the model in Figure 1.6.
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The influenza severity estimation of (Presanis et al., 2014) can be seen as
three cross-sectional analyses, one for each wave of infection, where severity
is expressed in terms of ratios of cumulative incidence of infection at different
levels of severity (Figure 1.1). The model is also stratified by age group
a ∈ {< 1, 1− 4, 5− 14, 15− 24, 25− 44, 45− 64, 65+}. The three timepoints
t ∈ {0, 1, 2} are not completely independent, as they share some parameters.
1.4.1 Model specification
1.4.1.1 First and second waves
Figure 1.7 displays the DAG corresponding to the first wave of infection,
in summer 2009 (t = 0 in the notation of Figure 1.6). The disease states
X(0) correspond to the numbers Nl of infections at each severity level l =
{I,S,H,ICU,D} (Figure 1.1). Note that age and wave/time indices have been
omitted in the DAG and what follows, for brevity.
Functional parameters Ideally, we would assume a nested binomial
structure for the states Nl ∼ Binomial(Nm, pl|m) for a severity level m lower
than l and for conditional probability pl|m of being a case at level l given in-
fection at level m. However, for computational reasons, we instead assume a
mean parameterisation such that generically, the states Nl are deterministic
functions
Nl =
⌊
pl|mNm
⌋
of the number Nm of infections at a lower level m of severity and the con-
ditional probability pl|m of being a case at level l given infection at level m.
The total population NPop is considered fixed. The case-severity risks of in-
terest, i.e. the case-hospitalisation (CHR), case-ICU admission (CIR) and
case-fatality (CFR) risks (Figure 1.1), are products of component conditional
probabilities:
CHR = pH|I = pH|S × pS|I
CIR = pICU|I = pICU|H × CHR
CFR = pD|I = pD|H × CHR.
The functional parameters ψ of Figure 1.6 are defined as the set ψ = {Nl, l ∈
{I,S,H,ICU,D}} ∪ {CHR, CIR, CFR} of states and the corresponding case-
severity risks.
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Observational model The observations, yi, i = 1, . . . , n, where n = 7
per age group, are either reported numbers of infections at different levels
of severity (yˆS, yH, yD in Figure 1.7), reported numbers of hospitalisations
that lead to severe events (yICU|H, yD|H), or the cross-sectional sero-prevalence
data before and after the first wave. Each observation is a realisation of
a binomial distribution, with probability parameters representing either: a
detection probability dl with size parameter the counts of the numbers of
infections Nl at levels l ∈ {S,H,D}; a conditional probability pICU|H or pD|H
with size parameter the subset of observed hospitalisations yH where the final
outcome yICU|H or yD|H or discharge was observed; or a sero-prevalence, either
before the first wave (pibaseline) or after the first wave (pi), with size parameter
the number of sera samples tested. The latter sero-prevalence data inform,
indirectly, the infection attack rate pI|Pop, via their difference.
Basic parameters The basic parameters θ of Figure 1.6 are the set θ =
{pl|m, l,m ∈ {I,S,H,ICU,D}}∪{dl, l ∈ {S,H,D}} of conditional and detection
probabilities in Figure 1.7. Each probability is given an independent flat
prior, apart from the symptomatic case-hospitalisation risk pH|S which is
assigned an informative prior based on external data.
pS|IpH|SpICU|HpD|H
yD
CHRCIRCFR
NINSNHNICUND
dSdHdD
yH
pI|Pop
NPop
pi
pibaseline Sero-survey data, 2008
Sero-survey data, 2009
yICU|HyD| H
Web-based hospital surveillanceDeaths reported to CMO/HPA based on GP consultations/virological testing
yˆS
Figure 1.7: DAG adapted from (Presanis et al., 2014) representing the first
wave of A/H1N1 pandemic influenza infection.
The second wave model is similar to that of the first wave, excluding only
the sero-prevalence data, due to the challenges of disentangling vaccinated
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cases from true infections in the sero-samples in the absence of good data on
vaccination in the dataset.
1.4.1.2 Third wave
The third wave model differs more substantially (Figure 1.8). Estimates
of the number of symptomatic infections were derived from a joint Bayesian
model of the GP consultation and virological positivity data from the smaller
sentinel system, regressed on age group and time. This sub-model was fit-
ted at a first stage, accounting for the probability of consulting a GP given
symptoms, and giving posterior mean (sd) estimates yˆS (σˆS) on a log scale.
In contrast to the first two waves, these estimates are not considered under-
ascertained. They are therefore incorporated in the third wave model, at
a second stage, via a likelihood term, assuming yˆS ∼ Normal(log(NS), σˆS).
Finally, since the hospitalisation data in the third wave (Figures 1.2 and 1.3)
pS|IpH|SpICU|HpD|H
yD
CHRCIRCFR
NINSNHNICUND
dD
pI|Pop
NPop
Deaths reported to CMO/HPA
yˆICU σˆICU
yˆS σˆS
dICUN
∗
ICU
yH
dH
USISSFrom ICU sub-model From GP ILI consultation and
virological positivity sub-model
Figure 1.8: DAG adapted from (Presanis et al., 2014) representing the third
wave of A/H1N1 pandemic influenza infection.
are sparse, they lead to uncertain and under-ascertained estimates of the
numbers hospitalised and the proportion of hospitalisations leading to ICU
admission. Extra prevalence-type data on the number Nt,ILIC of suspected
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ILI cases present in all ICUs in England are therefore incorporated, through
a sub-model for these data that assumes entrances at rate λt and exits at
rate µ to/from ICU form an immigration-death stochastic process (Presanis
et al., 2014) (Figure 1.9). Note that this ICU sub-model is another example
of a multi-state model as in Figure 1.6, where the state is Nt,ILIC. Since the
Nt,ILIC
λt µ
Figure 1.9: Immigration-death process model for ILI cases in ICU. λt is the
daily rate of admissions to ICU, Nt,ILIC the number of ILI cases present in
ICU on day t, and µ the rate of exit (discharges or deaths), so that the
expected length of stay in ICU is 1/µ.
observations are of influenza-like-illness rather than confirmed influenza, es-
timates of the ILI admission rate λt are combined with virological positivity
data from secondary care to obtain estimates of the cumulative number yICU
of new ICU admissions for A/H1N1 influenza. The posterior mean (sd) esti-
mates yˆICU (σˆICU) from this sub-model, on a log scale, are then incorporated
in the third wave model via a contribution to the likelihood:
yˆICU ∼ Normal(log(N∗ICU), σˆICU) (1.1)
where N∗ICU is considered a lower bound for the total number of A/H1N1 ICU
admissions, NICU, since the prevalent ICU case data cover only a portion of
the time period of the third wave. This lower bound is implemented through
a binomial assumption
N∗ICU ∼ Binomial(NICU, dICU)
with probability parameter representing a detection probability dICU.
In contrast to the first two waves, priors for the conditional probabilities
pt=3,l|m were expressed hierarchically by centering these probabilities, on a
logit scale, on their respective second wave versions, pt=2,l|m.
1.4.2 Results
Figure 1.10 and the left-hand side of Figure 1.11 give posterior summaries
of the symptomatic CFR (sCFR = pD|S), CFR and number of symptomatic
infections NS, by age and wave. Note that for the first two waves of infection,
the model giving these results assumes that the HPA-provided estimates of
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NS are under-estimates, with detection probability dS. In (Presanis et al.,
2014), discussion of the assumptions about the potential under-estimation
in HPA estimates of the number symptomatic led to a number of sensitivity
analyses. An initial unpublished sensitivity analysis assumed the HPA esti-
mates were unbiased, i.e. dS = 1, giving the posterior estimates of NS on the
right-hand side of Figure 1.11 for waves 1 and 2 only.
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Figure 1.10: Posterior median and 95% credible intervals of symptomatic
CFR and CFR, by wave and age group, log-scale.
Notable patterns include: the ‘u’-shaped age distribution of the case-
fatality risks and corresponding ‘n’-shaped age distribution of symptomatic
cases; and an age shift towards older ages over the three waves of infection.
The sensitivity analysis assuming dS = 1 gives lower estimates of NS (and
hence higher CSRs, not shown), but with a similar age pattern.
Further sensitivity analyses, as reported in (Presanis et al., 2014), sug-
gested the key age patterns were more robust to prior choices than to the
choice of bias/detection model for the HPA estimates.
1.5 Temporal estimation: transmission
Compartmental mechanistic models, typically used to describe the process of
disease transmission (see Section 1.2 and Chapter ?), can also be represented
as in Figure 1.6. The disease states X(t) are of the classic Susceptible (S),
Infected (I), Recovered (R) type and the transition rates λ(t) are functional
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Figure 1.11: Left: Posterior median and 95% credible intervals of number
of symptomatic infections, by wave and age group, log-scale. Right: Same
posterior summaries, but for a sensitivity analysis assuming dS = 1.
parameters defined in terms of the current disease states. In particular, for
the subset of λ(t) representing incidence rates, we define λInc(t) = f(X I(t))
where X I(t) is the current size of the infected and/or infectious states.
In (Birrell et al., 2011), the transmission of a novel pandemic A/H1N1
influenza strain among a fixed population stratified into A age groups is esti-
mated through the combination of a deterministic age-structured transmis-
sion model with disease and reporting models, describing disease transmis-
sion, progression and health-care seeking behaviour of infected individuals,
respectively.
1.5.1 Model specification
Transmission model The transmission dynamics are governed by a sys-
tem of differential equations of the type:
dS(t, a)
dt
= −λ(t, a)S(t, a)
dE(t, a)
dt
= λ(t, a)S(t, a)− 1
dL
E(t, a)
dI(t, a)
dt
=
1
dL
E(t, a)− 1
dI
I(t, a)
(1.2)
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where S(t, a), E(t, a), I(t, a) represent the number (or proportion) of the pop-
ulation of age group a, (a = 1, . . . , A) in the S (Susceptible), E (Exposed)
and I (Infectious) states at time t and dL and dI are the mean latent and
infectious periods. Transmission is driven by the time- and age-varying rate
λ(t, a) at which susceptible individuals become infected. The system in (1.2)
is evaluated using an Euler approximation at times tk = kδt, k = 0, . . . , K,
where the choice of δt = 0.5 days is sufficiently small that the probabil-
ity of more than one change of state per period is negligible. Under this
discretisation, at time tk the vector (Stk,a, Etk,a, Itk,a) gives the number of
individuals in each state with the number of new infections in [tk−1, tk) being
∆tk,a = λtk−1,aStk−1,a, where
λtk,a = 1−
A∏
b=1
{(
1−M (a,b)tk R0(φ)/dI
)Itk,b}
δt. (1.3)
Here R0 is the basic reproduction number, the expected number of secondary
infections caused by a single primary infection in a fully susceptible popula-
tion, often parameterised in terms of the epidemic growth rate φ (Wearing
et al., 2005); and the time-varying mixing matrices M tk , express the pat-
tern of transmission between age groups, with the generic entry M
(a,b)
tk
being
the relative rate of effective contacts between individuals of each pair of age
groups (a, b) at time tk. The quantity 1 − M (a,b)tk R0(φ)/dI gives the prob-
ability of an individual in age group a not being infected by an infectious
individual in age group b in the interval k + 1. When raised to the power
of all the infectious individuals in group b, the probability of not being in-
fected by any individual in group b is obtained. Taking the product over
all age groups gives the probability of not being infected at all. This ex-
pression for λtk,a is known as the Reed-Frost formulation (Ball, 1983). The
initial conditions of the system are determined by: parameter I0, the total
number of infectious individuals across all age groups at time t0; an assumed
equilibrium distribution of infections over the age groups; and an assump-
tion of initial exponential growth that determines the relationship between
the numbers in the four disease states. The mean latent period dL is taken
as known, whereas the mean infectious period dI is a parameter to be esti-
mated. Therefore, the dynamics of the transmission model (1.2) depend on
the basic parameter vector θT = (φ, I0, dI ,m), where m parameterise the
mixing matrices M tk . The transmission model is represented schematically
in DAG format in Figure 1.12. The dependency on age has been omitted in
the DAG and in what follows, for brevity.
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Figure 1.12: DAG representing the transmission model of (Birrell et al.,
2011).
Disease progression and health-care seeking The newly infected indi-
viduals ∆tk , following an incubation time, develop ILI symptoms with prob-
ability pSym (Figure 1.12). With probability pC, the symptomatic cases are
virologically confirmed through contact tracing or hospitalisation in the early
phase of the epidemic; and with time-varying probability pt,G, symptomatic
patients choose to contact a primary care practitioner (GP). These processes
result in the (latent) number of symptomatic cases Nts,Sym, confirmed cases
Ntu,C and GP consultations Ntv ,G, which can each be expressed as a convolu-
tion of the new infections ∆tk with the distribution of the time delay between
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infection and the relevant health-care event. For instance, the number Ntv ,GP
of GP consultations in the interval [tv−1, tv) is
Ntv ,GP = pSymptv ,G
v∑
k=0
∆tkf(v − k) (1.4)
where the (discretised) delay probability mass function f(·) accounts for both
the time from infection to symptoms and the time from symptoms to GP
consultation. The disease progression component of the model is specified
by basic parameters θD = (pSym, pC, ptv ,G) (Figure 1.12) and, from equation
(1.4), the quantities Ntu,C and Ntv ,G are complex functions of both θT and
θD.
Observational model The goal here is to estimate the rate of infections
λtk−1 over time and predict the resulting burden on health-care facilities,
through the estimation of the basic parameters θ = θT ∪ θD from observed
data. As anticipated in Section 1.2.2, direct data on the number of new
infections are not available. Therefore, a combination of a number of indi-
rect evidence sources informing different aspects of the infection and disease
processes needs to be used to estimate θ.
The observed data yt = (ytu,C, ytv ,G, ytv ,P, ytk,S) include: ytu,C, the counts
of confirmed cases during the initial weeks of the outbreak (Figure 1.4(D));
ytv ,G, the number of primary care consultations for ILI, including the indi-
viduals attending for non-pandemic ILI (Figure 1.4(A)); ytv ,P, the comple-
mentary virological data on nasopharyngeal positivity for A/H1N1 (Figure
1.4(C) and Section 1.2.1); and ytk,S, the cross-sectional sero-prevalence data
(Figure 1.4(B)). Typically there is some reporting delay between the disease
diagnoses and their appearance in health-care surveillance, but for simplicity,
here no such delay is assumed, so that yti,i is observed at the same time ti as
the disease endpoint Nti,i for each i. Each item of data informs θ through a
probabilistic link.
More specifically, ytk,S is a realisation of a Binomial distribution,
ytk,S ∼ Binomial (ntk,S, ψtk,S) ,
with sample size ntk,S and probability ψtk,S = 1 − StkN . The sero-prevalence
data ytk,S therefore directly inform the number of susceptibles Stk and pa-
rameters θT as Stk = Stk(θT ).
The counts of confirmed cases ytu,C and ILI consultations ytv ,G are taken
as realisations of negative binomial distributions, with means given by
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functional parameters ψtu,C and ψtv ,G respectively, and time-varying over-
dispersion parameter ηt, i.e.
ytv ,G ∼ Negative Binomial (ψtv ,G, ηtv)
where
ψtu,C = Ntu,C
ψtv ,G = Ntv ,B +Ntv ,G
and are, therefore, functions defined by convolution equations of the type in
(1.4).
To disentangle the GP ILI consultations due to the pandemic strain,
Ntv ,G, from all other ILI consultations, Ntv ,B, information is needed on the
proportion of all GP ILI consultations that result from the pandemic strain.
This information is provided by virological positivity data, where observed
positive samples ytv ,P are considered realisations of a Binomial distribution,
ytv ,P ∼ Binomial (ntv ,P, ψtv ,P) ,
with sample size (number of tests) ntv ,P and probability parameter ψtv ,P =
1 − Ntv,B
Ntv,B+Ntv,G
. The proportion positive, ψtv ,P, is expressed as a function of
the disentangled counts Ntv ,B and Ntv ,G. As in Section 1.4.1.2, the proportion
positive ψtv ,P and number of ILI consultations ψtv ,G are jointly regressed on
age and time, on logit and log scales respectively. The background counts
Ntv ,B are therefore a function of the regression parameters βB (Figure 1.12).
In each generic calendar time interval [tj−1, tj], as indicated in Section
1.3, the likelihood of the data is the product
L(ytj | θ) =
∏
i∈{C,G,P,S}
L(ytj ,i | θ) (1.5)
of the contributions L(ytj ,i | θ) of the four data streams, as these are consid-
ered to be independent conditional on their common parents. The posterior
distribution is then obtained by combining the likelihood with the prior dis-
tribution p(θ).
1.5.2 Results
Figure 1.13 shows the posterior distribution for the number of new A/H1N1
infections by age group in London, revealing the two waves of infection in
summer and autumn/winter 2009. The first wave of infection has a higher
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Figure 1.13: Posterior median (solid lines) and 95% credible interval (dashed)
lines number of new infections per week in London, overall and by age group.
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Figure 1.14: Predictions of the weekly number of new infections in London,
at days 83 and 192 of the epidemic (vertical dashed lines): posterior median
(black line) and 95% predictive intervals (shaded areas). For the day 192
prediction, paler shaded areas represent the predictive intervals at two pre-
vious timepoints (days 83 and 143 respectively, shown by the grey vertical
lines).
peak, whereas the second wave, particularly by age group, is spread over a
longer period of time, resulting in a higher attack rate in the second wave.
R0 is estimated to be 1.65 (95% credible interval 1.56-1.75).
Figure 1.14 shows predictions forward in time based on the data up to
days 83 and 192 of the epidemic respectively. Note how the uncertainty in
the predictions is progressively reduced as data accumulate.
1.6 Model building, inference and criticism
The two influenza case studies above, although relatively simple, have demon-
strated how the combination of multiple sources can easily lead to complex
probability models. This complexity can challenge standard inferential tools,
motivating the development of novel approaches. In what follows, we con-
tinue to use the two influenza examples to illustrate such new approaches to
model building, efficient inference and model criticism.
CHAPTER 1. ANALYSING MULTIPLE EPIDEMIC DATA SOURCES25
1.6.1 Strategies for model building
There are two strategies to build a complex evidence synthesis model: (i) all
the data are combined simultaneously, as in joint models (e.g. (Rizopoulos,
2012)); or (ii) the model is assembled in stages, using subsets of the evidence
initially, before combining the results in a second stage, as in standard meta-
analysis (Borenstein et al., 2009). When a model is complex, the latter
strategy is sensible, to understand what might be inferred from each dataset
in isolation. A staged approach is used in both the influenza examples of
Sections 1.4 and 1.5. For example, in the severity model, a sub-model of a
stochastic process describing entries to/exits from ICU is first fitted to the
ICU prevalent case data in the third wave, before combining the results in the
full evidence synthesis model. In the transmission model, a joint regression
model of GP consultation and virological positivity data was fitted initially,
before the results were incorporated in the transmission model to disentangle
“background” non-influenza noise from the signal of influenza consultations.
To illustrate a two-stage process, we use the severity example. Figure 1.15
shows a simplified schematic DAG of the stages: in both the stage 1 and stage
2 models, the cumulative number of ICU admissions measured over the time
period of the ICU prevalence data, N∗I , has a prior model. The stage 1 prior
is in terms of the parameters of the ICU entry/exit process, λt and µ; whereas
the stage 2 prior is in terms of the parameters of the period-prevalence-type
severity model, i.e. the conditional and detection probabilities described in
Section 1.4.
NI
dIN
∗
I
. . .
Rest of severity
model
(b) Stage 2(a) Stage 1
N∗INt,ILIC
yt
λtµ
??
Figure 1.15: Two-stage modelling strategy for joining ICU sub-model with
rest of severity model.
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The existence of two prior models poses the question of how to combine
the two sources of information. In (Presanis et al., 2014), the problem was
solved using an approximate method, transferring the posterior mean (sd)
estimate of N∗I from the stage 1 ICU sub-model to the stage 2 severity model
via a likelihood term (equation (1.1) and Figure 1.8), such that the posterior
of log(N∗I ) from the ICU sub-model is approximated by a Normal distribu-
tion. This approximate approach is acceptable when the approximation is
good, i.e. when the sample size in the stage 1 model is large enough to guar-
antee a Gaussian posterior distribution. If not, in (Goudie et al., 2018), an
alternative, more general, exact method for joining (and splitting) models,
“Markov melding”, is proposed.
In general terms, suppose we haveM probability submodels pm(φ, ψm, Ym),
m = 1, . . . ,M , with parameters φ and ψm and observable random variables
Ym. Suppose further that φ is common to all modules, acting as a ‘link’ be-
tween the submodels, and that the aim is to combine all modules into a single
model pcomb(φ, ψ1, . . . , ψM , Y1, . . . , YM), so that the posterior distribution for
the link parameter (φ) and the submodel-specific parameters ψm reflects all
information and uncertainty. In some cases, such model joining is readily
achievable using standard hierarchical modelling constructs. However, there
are some contexts where this joining is not straightforward, in particular
where: (i) some sub-models may not be expressible conditional on the link
parameter φ, particularly if φ is a non-invertible deterministic function of
other parameters in a sub-model; (ii) the prior marginal distributions pm(φ)
for φ differ in different submodels. Both of these situations arise in the sever-
ity estimation of Section 1.4 and Figure 1.15, where the link parameter φ is
the cumulative number of ICU admissions N∗I .
Markov melding (Goudie et al., 2018) addresses model joining in these
contexts by building on Markov combination (Dawid and Lauritzen, 1993;
Massa and Lauritzen, 2010; Massa and Riccomagno, 2017) and Bayesian
melding (Poole and Raftery, 2000) ideas. Markov combination allows joining
of sub-models under the restrictive constraint that the prior marginals pm(φ)
are identical for each m, i.e. the submodels pm(φ, ψm, Ym), m = 1, . . . ,M
are consistent in the link parameter φ: pm(φ) = p(φ) for all m. In practice,
however, the marginal distributions pm(φ) are usually not exactly identical,
as in Figure 1.15. Markov melding therefore exploits the Bayesian melding
approach (Poole and Raftery, 2000) to replace each marginal with a pooled
marginal distribution
ppool(φ) = g(p1(φ), . . . , pM(φ))
, where g is a pooling function chosen such that
∫
g(φ) dφ = 1 and ppool(φ)
is an appropriate summary of the individual marginals. Since each replaced
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Figure 1.16: Pooled prior marginal distributions under different pooling func-
tions for the ICU and severity sub-models.
model is now consistent in φ, the Markov melded model can be obtained via
a Markov combination of the replaced models:
pMM(φ, ψ1, . . . , ψM , Y1, . . . , YM) = ppool(φ)
M∏
m=1
pm(φ, ψm, Ym)
pm(φ)
.
Different possible pooling functions g for the melded marginal ppool(φ)
are discussed in (Goudie et al., 2018). Once the new model pMM has been
formed, posterior inference given all the data y1, . . . , yM can be performed.
Markov melding incorporates more data than any single submodel, and so will
provide more precise inferences if the various components of evidence (priors
and data) in each submodel do not substantially conflict. Otherwise, Markov
melding may be misleading, so, before proceeding, the underlying reasons for
the conflict should be investigated and resolved (see section 1.6.3).
Note that the Markov melding method can, of course, be generalised to
the case of multivariate link and submodel-specific parameters, φ and ψm
(Goudie et al., 2018).
Markov melding in the influenza severity example For the severity
example, the use of Markov melding on the ICU and severity sub-model im-
plied priors (Figure 1.16) results in greater posterior precision under different
pooling functions, in comparison to both the sub-model posteriors alone and
the normal approximation employed in (Presanis et al., 2014) (Figure 1.17).
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Figure 1.17: Posterior distributions (medians and 95% credible intervals) for
the ICU and severity model parameters under the Markov melded model
with different pooling functions, in comparison to the separate sub-model
posterior distributions.
1.6.2 Computationally efficient inference
Markov chain Monte Carlo (MCMC) methods (Gamerman and Lopes, 2006)
have become standard tools in Bayesian inference to sample from posterior
distributions. This sampling, in cross-sectional estimation problems of the
type in Section 1.4 (e.g. (McDonald et al., 2014a)), can feasibly be carried
out using available software implementing MCMC (e.g. (Lunn et al., 2009)).
On the other hand, inference for more complex models, such as transmission
models similar to that of Section 1.5 (e.g. (Dorigatti et al., 2013)), requires
bespoke code and a tailored MCMC algorithm. However, classical MCMC is
often not a computationally viable option in stochastic transmission models
when the data structure is complex (e.g. (Shubin et al., )) and can be-
come computationally inefficient even in inference for deterministic models,
when inferences are required within a restricted time frame. Alternative ap-
proaches to Bayesian inference are becoming popular, often combined with
MCMC, to tackle such computational challenges. Examples include Approx-
imate Bayesian Computation (ABC) (e.g. (Ratmann et al., 2012)), used to
estimate the likelihood; Sequential Monte Carlo (SMC) (e.g. (Sheinson et al.,
2014)), where inference is sequentially updated using only the most recent
data; and emulation (Farah et al., 2014) and history matching (Andrianakis
et al., 2017), where a complex transmission model is replaced by a simpler
approximate model.
As a concrete illustration, we re-visit the deterministic transmission model
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of Section 1.5, where the goal is to reconstruct retrospectively the evolution
of the influenza A/H1N1 epidemic. In (Birrell et al., 2011), an adaptive
Metropolis Hasting algorithm is used to derive the posterior distribution of
θ using 245 days of GP consultation data, combined with the various addi-
tional sources of information. To reconstruct the epidemic in London, each
run of the MCMC algorithm requires around 7 × 105 iterations to reach
convergence, taking more than four hours for a single MCMC chain The bot-
tleneck is the evaluation of the likelihood in equation (1.5), which involves
calculation of the computationally expensive convolutions in equation (1.4).
This is an acceptable computational burden in the case of retrospective in-
ference. However, in the midst of an epidemic, prospective estimation and
prediction will be needed as new data arrive, for instance, daily. Then the
MCMC algorithm would have to be rerun each day to re-analyse the com-
plete dataset, which would not be optimal, particularly if alternative models
need to be explored. More efficiently, the posterior distribution at each new
time point could be derived from the one at the previous time point. In
(Birrell et al., 2016), a hybrid SMC algorithm is developed to enable this
more efficient use of the information and carry out inference and predictions
in real time. The idea underlying SMC is to derive sequential posterior dis-
tributions pik(θ) = p(θ | yt1:tk) ∝ p(θ)L(yt1:tk | θ) for k = 1, . . . , K as data
accumulate. At each time point tk the distribution pik(θ) is approximated
by nk particles {θ(1)k , . . . ,θ(nk)k } with corresponding weights {ω(1)k , . . . , ω(nk)k }.
As data ytk+1 arrive at tk+1, pik(θ) serves as an importance distribution and
the updated pik+1(θ) is obtained by re-weighting the sample {θ(1)k , . . . ,θ(nk)k }
by the importance ratios
pik+1
(
θ
(j)
k
)
pik
(
θ
(j)
k
) for each j ∈ 1, . . . , nk.
In the model of (Birrell et al., 2016) this ratio reduces to the likelihood
of the new data, so that the jth particle has weight
ωjk+1 ∝ ωjk
pik+1
(
θ
(j)
k
)
pik
(
θ
(j)
k
) = ωjkL(yk+1 | θ(j)k ).
This simple SMC scheme works well when the data follow a stable pat-
tern, as demonstrated in settings where only one data stream is available
(e.g. (Ong et al., 2010)). However, in the specific application of (Birrell
et al., 2016), the challenge is not particularly posed by the multiplicity of
data, rather by the sudden change in the pattern of health seeking behaviour
produced by a public health intervention (see Figure 1.4(A)). Such a change
introduces a shock to the system and complicates dramatically the tracking
of the sequential distributions pik(·) over time. On arrival of a particularly in-
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Table 1.1: Deviance summaries for ‘data’ on number symptomatic in first
wave, log-scale, by age group, for the “naive” model: HPA estimate (yˆS)
and corresponding standard deviation (σˆS); posterior mean estimate (NS)
and corresponding 95% credible interval (CrI); posterior mean deviance con-
tributions (D); plug-in deviance at posterior mean of parameters (D(θ));
effective number of parameters (pD); deviance information criterion (DIC).
Age yˆS σˆS NS 95% CrI D D(θ) pD DIC
< 1 8.11 0.30 8.27 7.70 8.85 1.32 0.32 1.01 2.33
1-4 7.81 0.26 9.89 9.42 10.38 66.72 65.80 0.92 67.65
5-14 9.78 0.28 11.75 11.32 12.16 49.16 48.58 0.58 49.74
15-24 10.23 0.26 11.17 10.74 11.62 14.05 13.30 0.76 14.81
25-44 11.46 0.29 11.30 10.83 11.80 1.03 0.30 0.73 1.75
45-64 12.03 0.26 10.06 9.61 10.52 59.17 58.36 0.81 59.98
65+ 11.25 0.27 7.62 7.12 8.15 175.41 174.49 0.92 176.33
formative new batch of data ytk+1 , the sample {θ(1)k , . . . ,θ(nk)k } degenerates to
the few particles consistent with the new information, which, carrying large
weights, give a misleading estimate of pik+1(·). The naive SMC algorithm
is then adapted to handle these highly informative observations by: intro-
ducing resampling and MCMC jittering steps (Gilks and Berzuini, 2001) to
rejuvenate the sample; and by sequentially including only fractions of the
new data to minimise the divergence between posterior distributions at con-
secutive times (Del Moral et al., 2006; Neal, 1996). The result is a hybrid
semi-automatic SMC algorithm that is more computationally efficient than
the original MCMC, is highly parallelisable, and can deal with sudden shocks
in the observational patterns.
1.6.3 Model criticism: conflict and influence
Model criticism is crucial to any analysis. However, specific to the context of
multiple source evidence synthesis are: the potential for conflicting evidence,
with such conflicts needing to be detected, quantified and resolved; and the
critical assessment of what the role and influence of different sources is.
In the influenza severity example of section 1.4, the initial sensitivity
analysis shown in the right-hand side of Figure 1.11 did not include a de-
tection probability dS for the HPA estimates yˆS of the number symptomatic
(i.e. with dS = 1). However, this “naive” model led to high posterior mean
deviances, as shown in Table 1.1 for ‘data’ yˆS on a log scale for the first wave.
By comparison, the model assuming the HPA estimates are under-estimates
has much lower posterior mean deviances and DIC contributions (Table 1.2).
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Table 1.2: Deviance summaries for ‘data’ on number symptomatic in first
wave, log-scale, by age group, for the model assuming HPA estimates are
under-estimates.
Age yˆS σˆS NS 95% CrI D D(θ) pD DIC
< 1 8.11 0.30 8.11 7.56 8.66 0.89 0.00 0.89 1.78
1-4 7.81 0.26 9.71 9.20 10.23 0.92 0.06 0.85 1.77
5-14 9.78 0.28 11.45 10.93 11.95 0.82 0.00 0.82 1.64
15-24 10.23 0.26 11.11 10.64 11.58 1.00 0.23 0.77 1.76
25-44 11.46 0.29 11.22 10.71 11.72 0.90 0.00 0.90 1.80
45-64 12.03 0.26 9.91 9.41 10.41 0.86 0.00 0.86 1.73
65+ 11.25 0.27 7.56 7.03 8.10 0.92 0.00 0.92 1.84
The lack of fit in the “naive” model motivated a closer look at the consistency
of the different sources of evidence about the denominators, or infections at
lower levels of severity (asymptomatic and symptomatic), resulting in both
the sensitivity analyses of (Presanis et al., 2014) and more formal conflict
assessment in (Presanis et al., 2013).
Conflict assessment methods Bayesian predictive diagnostics (e.g.
(Box, 1980; Rubin, 1984; Gelman et al., 1996; Bayarri and Castellanos,
2007)) have long been used in model assessment, comparing observations
to predictions from the model. Posterior predictive tests (Gelman et al.,
2003) are known to be conservative, due to using the data both to fit the
model and to compare to model predictions, so a variety of (computationally
intensive) post-processing, approximate, or cross-validatory methods have
been proposed instead (e.g. (Bayarri and Berger, 2000; Bayarri and Castel-
lanos, 2007; Hjort et al., 2006; Steinbakk and Storvik, 2009; Gelman et al.,
1996; Marshall and Spiegelhalter, 2007)). Typically, each of these methods
have been employed to assess models of a single dataset, rather than for an
evidence synthesis.
“Conflict p-values” (Marshall and Spiegelhalter, 2007; G˚asemyr and
Natvig, 2009; Presanis et al., 2013; G˚asemyr, 2016) have been proposed as a
generalisation of Bayesian cross-validatory predictive p-values that compare
not only subsets of data to predictions resulting from the rest of the data,
but also whole sub-models, comprising data, model structure and prior infor-
mation, with predictions from the rest of the model. The key idea, known as
“node-splitting”, is to split a DAG G(φ,θ\φ,y), comprising data y and latent
quantites θ = (φ,θ\φ), into two independent partitions at any “separator”
node φ, G(φa,θa\φ,ya) and G(φb,θb\φ,yb). Two copies of the separator φ are
created, φa and φb, that are each identifiable in partitions G(φa,θa\φ,ya) and
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G(φb,θb\φ,yb) respectively. The aim is to compare the posterior distributions
from each partition, p(φa | ya) and p(φb | yb).
This comparison is achieved by defining a difference function δ = h(φa)−
h(φb), on an appropriate scale h(·), and considering where 0 lies in the pos-
terior distribution of the difference, pδ(δ | ya,yb). A two-sided conflict p-
value corresponding to the hypothesis test H0 : δ = 0 is defined as c = 2 ×
min [Pr {pδ(δ | ya,yb) < pδ(0 | ya,yb)} , 1− Pr {pδ(δ | ya,yb) < pδ(0 | ya,yb)}],
with different methods for evaluating c and one-sided variations given in
(G˚asemyr and Natvig, 2009; Presanis et al., 2013). The conflict p-value has
been demonstrated to be uniform under the null model in a range of models
by (G˚asemyr, 2016). This setup can be generalised to multiple partitions
and multiple node-splits (Presanis et al., 2017).
Conflict in the influenza severity example To assess whether the lack
of fit to the HPA estimates of the number symptomatic in the “naive” model
(Table 1.1) could be due to conflicting evidence, the model for the first wave
only is split into two partitions at NS, as in Figure 1.18. The “parent” par-
tition comprises the data and priors informing the parent nodes of NS, i.e.
the sero-prevalence data and an informative prior for the proportion of infec-
tions that are symptomatic, pS|Inf. The rest of the evidence (the severe case
data and priors) comprises the “child” model. The test for conflict between
pS|IpH|SpICU|HpD|H
yD
NIN
parent
S
NHNICUND
dHdD
yH
pI|Pop
NPop
pi
pibaseline Sero-survey data, 2008
Sero-survey data, 2009
yICU|HyD|H
Web-based hospital surveillanceDeaths reported to CMO/HPA based on GP consultations/virological testing
yˆS
NchildS
Figure 1.18: DAG showing node split at NS. On the right is the “parent”
model and on the left the “child” model. The double-headed arrow represents
the comparison between the two.
the parent and child models demonstrated low posterior probabilities of no
conflict, particularly for the youngest and oldest age groups (Presanis et al.,
2013). The posterior difference function δ = log10(N
parent
S ) − log10(N childS )
is plotted for the age group 65+ in Figure 1.19, together with the conflict
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p-value c = 0.058 and the corresponding posterior distributions for the two
partitions and the full model. Note that the sero-prevalence data in the par-
ent model imply a much higher, though also much more uncertain, number
symptomatic than the severe case data in the child model. The lack of cer-
tainty in the sero-prevalence data means the severe case data and priors have
more influence in the full model, so the full model posterior is much closer
to the child model posterior than the parent one.
c =  0.058
0
1
2
3
−1 0 1 2 3 4 5
Posterior log_10(number symptomatic)
D
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Difference: parent − child Full model Parent model Child model
Ages 65+
Figure 1.19: Conflict (posterior difference) at NS between the parent and
child models in age group 65+ in the first wave: difference function δ =
log10(N
parent
S )− log10(N childS ) (dark grey); log10(NS) from full model (medium
grey); log10(N
parent
S ) from parent model (light grey); log10(N
child
S ) from child
model (ivory).
A similar investigation of conflict at a different node in the “naive” model,
the number of hospitalisations NH, leads to splitting the DAG into three par-
titions (not shown), based on: the sero-prevalence data; the hospital data;
and the mortality data, respectively. The influence of the evidence in the
three partitions on the full model is shown in Figure 1.20. As in the previous
example, the sero-prevalence (denominator) data in partition 1 are the most
uncertain, with the hospital data partition (2) having less uncertainty, and
the mortality data partition (3) even less uncertainty. The posterior distri-
butions for all three partitions overlap substantially however, so that conflict
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Figure 1.20: Influence and conflict at NH between the three partitions in age
group 45-64 in the first wave.
is not detectable. Instead, when the three partitions are combined in the full
model, we obtain a much more precise estimate of the number hospitalised,
which is a compromise between the three partitions, as would be expected.
1.7 Discussion
This chapter has illustrated both the advantages and complexities of syn-
thesising multiple data sources to estimate various hidden characteristics of
infectious disease, through the two examples of severity and transmission es-
timation for influenza. Section 1.6 introduced three sets of tools to approach
the challenges of complex model building, computationally efficient inference
and model criticism respectively. However, these tools are a first step in
resolving these challenges, with a number of questions remaining open.
Markov melding generalises existing ideas that facilitate realistic evidence
synthesis, via a modular approach to model building. Some outstanding chal-
lenges include: the choice of pooling function; and the degree of heterogeneity
between prior models that is acceptable for Markov melding to be appropriate
– when does heterogeneity become conflict? Nevertheless, Markov melding
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is an important step in this era of big data, generalising divide-and-conquer
approaches (Bardenet et al., 2017).
Efficient inference for transmission models has been introduced using a
sequential approach. Currently, the sequential approach is highly tailored to
accommodate shocks to the system, so a question of interest is how to adapt
a transmission model structure in real-time, to be able to generalise the SMC
approach to any plausible epidemic scenario. The influenza model illustrated
is deterministic in its dynamics, and the generic multi-state model descrip-
tion in Section 1.3 and Figure 1.6, while in theory accommodating stochastic
dynamic transmission, is more focussed on deterministic dynamics. An im-
portant area of research is to consider efficient, real-time, inference from mul-
tiple sources for stochastic epidemics, particularly in the early stages of an
outbreak (Birrell et al., 2018). The influenza transmission model of (Shubin
et al., ) includes several levels of stochasticity and data, but is highly com-
putationally intensive, and therefore not feasible in real-time. How much
stochasticity is therefore necessary to realistically model an emerging out-
break?
The illustration of conflict assessment in Section 1.6.3 is targeted, in that
conflict was assessed at particular nodes in the DAG of the influenza severity
model, following suspected biases in particular data sources. However, in
some contexts, it may not be so clear where to look for potential conflict,
in which case a systematic search throughout a DAG for conflict may be
warranted. However, such systematic assessment entails multiple tests, ei-
ther through a multivariate difference function (as in the example of Figure
1.20) or through fitting multiple node-split models. A framework for system-
atic assessment, accounting for the multiple tests and their correlation, has
therefore been proposed (Presanis et al., 2017). Further open questions in
this area include how to improve power to detect conflict, and how to make
such methods more accessible by improving the computational feasibility of
systematic conflict assessment. As with any cross-validatory framework, mul-
tiple node-splitting can be computationally burdensome, so for hierarchical
models, (Ferkingstad et al., 2017) have proposed an INLA approach to fast
conflict diagnostics. A final area of open research related to understanding
the influence of different, potentially conflicting, evidence sources on infer-
ence is the adaptation of value of information methods to evidence synthesis
(Jackson et al., 2017).
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